Forward Citations = 7

Loading Chart...

5 inventors (with patents filed for the assignee):

Laurent Levy (7 out of 27 patents)

Agnès Pottier (6 out of 12 patents)

Marie-Edith Meyre (5 out of 16 patents)

4. Elsa Borghi (2 out of 4 patents)

5. Agnes Pottier (1 out of 13 patents)

7 patents: Sort by Forward Citations

1. 12653890 - Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer (2026-06-16),

2. 11819548 - Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer (2023-11-21),

3. 11717684 - Nanoparticles for use for treating a neuronal disorder (2023-08-08),

4. 11497717 - Nanoparticles for use for treating a neuronal disorder (2022-11-15),

5. 11471482 - Nanoparticles for use in enhancing brain performances or in treating stress (2022-10-18),

6. 11278723 - Nanoparticles for use for treating a neuronal disorder (2022-03-22),

7. 11247054 - Nanoparticles for use for enhancing brain performances or for treating stress (2022-02-15),

Company Overview

Nanobiotix S.A. is a French clinical-stage nanomedicine company pioneering new approaches to significantly change outcomes for patients fighting cancer. The company's proprietary nanotechnology platform, NanoXray, enhances the efficacy of radiotherapy without increasing toxicity. Nanobiotix is focused on developing its lead product NBTXR3 across multiple cancer types using radiation therapy, immunotherapy or chemoradiation regimens.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#451 in Paris

#2,219 in France

Paris, France

Nanobiotix S.a.

Forward Citations = 7

5 inventors:

Laurent Levy (7 out of 27 patents)

Agnès Pottier (6 out of 12 patents)

Marie-Edith Meyre (5 out of 16 patents)

4. Elsa Borghi (2 out of 4 patents)

5. Agnes Pottier (1 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanobiotix S.a.. Retrieved from https://idiyas.com/company/nanobiotix-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]